A Planned Phase III Trial of Neratinib Plus Temsirolimus for Patients With Metastatic HER2-Breast Cancer.
Phase of Trial: Phase III
Latest Information Update: 02 Mar 2015
At a glance
- Drugs Neratinib (Primary) ; Temsirolimus
- Indications Breast cancer
- Focus Therapeutic Use
- Sponsors Puma Biotechnology
- 02 Mar 2015 According to Puma Biotechnology, Inc. media release, company is planning to initiate this trial in the second half of 2015.
- 02 Mar 2015 Planned initiation date changed from 1 Dec 2014 to 1 Jul 2015, as reported by Puma Biotechnology, Inc. media release.
- 13 Nov 2013 Planned initiation date changed from 1 Dec 2013 to 1 Jun 2014.